Synovis Life Technologies (SYNO) Reports Mixed Q4 Earnings
More News related to SYNO
- Synovis Life (SYNO) Posts In-Line Non-GAAP Q3 EPS of 5c
- Synovis Life Technologies Reports 18 Percent Revenue Growth for Fiscal 2009 Fourth Quarter
- Trading Radar for 12/2: Aeropostale (ARO), Synopsys (SNPS), Shanda Interactive (SNDA), Jo-Ann Stores (JAS) Report
- Synovis Life's (SYNO) Veritas Collagen Matrix Published in American Journal of Surgery
- Synovis Life Technologies Announces Publication of Veritas(R) Article in The American Journal of Surgery
More News related to Earnings
- Highlights From SWHC Q2 Conference Call: First Qtr Reflected Results From Two Segments Under S&W Umbrella; Guides Below for Q3
- NASB Financial (NASB) Posts Q4 EPS of $0.77, Tops Views
- Highlights From Take-Two Interactive Softwares' (TTWO) Forecast Teleconference
- Saks (SKS) Restates Q3 EPS to $0.04, Up from $0.01
- Big Lots (BIG) Delivers With Strong Q3 Results and Guidance
Synovis Life Technologies, Inc. (Nasdaq: SYNO) reports Q4 EPS of $0.15, 1 cent better than the analyst estimate of $0.14. Revenue for the quarter was $12.7 million, versus the consensus of $13.79 million.
Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, marketing, and sale of products for the surgical treatment of disease.
Related Categories
EarningsStocks Mentioned
+0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
